Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05206695 · ClinicalTrials.gov registry record · NA
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
A NA study of Asthma and Pneumonia, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 3,840
- Enrollment target
- 1
- Study location
NCT05206695: Active NA study of Asthma and Pneumonia, sponsored by University of California, San Francisco.
NCT05206695 is a NA study of Asthma and Pneumonia that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 3,840 participants, above the 1,553-participant average among 374 other Asthma trials with a reported enrollment target (147% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05206695, a NA study of Asthma and Pneumonia, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,840 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervention will be associated with significantly greater increases in clinicians' adoption of evidence-based practices compared to control. The study is a pragmatic, cluster-randomized trial in US community hospitals. The primary outcome will be adoption of evidence-based practices over a sustained period of 2 years. Secondary outcomes include length of hospital stay, intensive care unit transfer, and hospital readmission/emergency department revisit.
Primary Outcome
Administration of narrow spectrum antibiotic
Conditions Studied
Interventions
- BEHAVIORAL Multi-condition Pathway Intervention
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,840 participants |
| Start Date | 2022-05-13 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05206695 still lists
NCT05206695 is an interventional study that assigns participants to a tested intervention. Its 3,840 participants enrollment target places it among the larger protocols in the corpus, above the 1,553-participant average among 374 other Asthma trials with a reported enrollment target (147% higher).
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Multi-condition Pathway Intervention is the first listed.
NCT05206695 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05206695 about?
NCT05206695 is a clinical study titled "Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children". This study's objective is to identify and test pragmatic and sustainable strategies for implementing a multi-condition clinical pathway intervention for children hospitalized with asthma, pneumonia, or bronchiolitis in community hospitals. The hypothesis is that the multi-condition pathway intervent...
What is the current status of trial NCT05206695?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,840 participants. The study started on 2022-05-13. Estimated completion is 2026-06-30.
What conditions does trial NCT05206695 study?
This clinical trial studies the following conditions: Asthma, Pneumonia, Bronchiolitis.
What interventions are being tested in trial NCT05206695?
The interventions under investigation include: Multi-condition Pathway Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05206695?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05206695 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05206695's enrollment target sits among peer trials
3,840 13th of 374 higher than 362 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT05919342 · 3,904 participants · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
- NCT03936335 · 3,930 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI